Alpha memo: resveratrol exercise context boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• Receipt 2's ~45% reduction statistic is reported but not fully quoted; phrase 'oxidised LDL–related measure' is appropriately hedged but could be tightened once the exact endpoint is confirmed against the full text.
• The 'Why this is surprising' framing could more explicitly state that Receipt 1 shows feasibility/safety rather than adjunct efficacy signal, to avoid any inference that Receipt 1 established benefit.

Reviewer note

Bounded alpha-memo that does exactly what is expected: integrates two primary RCT receipts into a single context-boundary signal on resveratrol as an exercise adjunct. Research question is specific (does resveratrol help or hinder exercise adaptations, and under what context?), and the title/source alignment is clean — both bundles concern resveratrol + exercise in older adults, populations and doses are reported accurately from the abstracts, and Receipt 2's ~45% figure matches the excerpt. The synthesis is coherent: Receipt 1 establishes feasibility/tolerability framing that could imply adjunction is worthwhile, Receipt 2 supplies the directional counter-signal on cardiovascular training adaptations, and the memo correctly refuses to collapse the two trials into a single verdict, instead naming the boundary (population, dose, duration, endpoint family) and listing confounders. Caveats/falsifiers section is unusually strong — confounder axes are enumerated, sample-size limits are stated, and a decisive future falsifier (powered RCT with pre-specified CV-adjacent + physical-function co-primary, ≥1 dose, ≥12 weeks) is specified. Limitations and gaps are specific and actionable, not generic. No clinical, policy, investment, or consensus claims are made. Source grounding is direct: both DOIs resolve, populations/doses/durations/excerpts match the bundle, and the cross-compound/cross-modality contrast is anchored to the named receipts rather than externalized. Honest about pilot N=60 and small N=27 limits. Recommendation: accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis